The Rational Emotive Behavioral Group Therapy for Depression and Anger of Patients with Multiple Sclerosis
- PDF / 482,687 Bytes
- 5 Pages / 595.276 x 790.866 pts Page_size
- 61 Downloads / 186 Views
MEDICINE
The Rational Emotive Behavioral Group Therapy for Depression and Anger of Patients with Multiple Sclerosis Homa Shahkaram 1 & Shahab Lotfinia 1
&
Azizollah Mojahed 1 & Erfan Farhangian 2 & Yazdan Madadjoo 1
Accepted: 19 May 2020 / Published online: 29 May 2020 # Springer Nature Switzerland AG 2020
Abstract The current study aims to determine the effectiveness of rational emotive behavioral therapy (REBT) base group therapy on anger and depression of patients with multiple sclerosis (MS). This randomized controlled trial study conducted with pre-test, post-test, and control group. Data was collected using the Beck depression inventory (BDI) and State-Trait Anger Expression Inventory 2 (STAXI-2). A total of 18 patients from the MS Society of Zahedan southeast of Iran participated in this study and randomly assigned to the intervention and control groups. The intervention group takes rational emotive behavioral therapy over 89-min sessions. The results of ANOVA repeated measures showed that rational emotive behavioral therapy has significantly reduced the depression of patients with multiple sclerosis (P < 0.05). However, the anger of these patients was not significantly reduced after treatment. The findings of this research indicate that REBT is not reducing the anger of patients with MS. These findings may be a guideline for experts to examine the other approaches for reducing the anger problem of these patients. Keywords Multiple sclerosis . Anger . Depression . Psychotherapy . Rational-emotive
Introduction Multiple sclerosis (MS) is an inflammatory and acquired disabling neurological disease of the central nervous system (CNS) that often starts in young adulthood and affects approximately 2.3 million people all around the world [26]. Patients with MS struggle with many physical, mental, and emotional challenges [11]. It has been estimated that approximately more than 50% of people with MS experience depression [24]. Depression symptoms have extensive consequences for both mental and physical health of these patients, including pain, enhanced fatigue, immune functioning, exacerbation of the disease, lowered adherence to medication, and diminished quality of life [18]. Despite this fact that depression in MS is linked with lesions in specific areas of the CNS or not, the This article is part of the Topical Collection on Medicine * Shahab Lotfinia [email protected] 1
Department of Clinical Psychology, Zahedan University of Medical Science, Zahedan, Iran
2
Department of Psychology, Islamic Azad University of Kermanshah, Kermanshah, Iran
enigma has interested recently. This question has remarkable importance for understanding and treating the depression in patients with MS. It may also be necessary for the knowledge of the complicated relationship between biological and psychosocial factors in the development of depression [24]. It shows that patients with MS who receive no treatment are likely to become more depressed over time. This observation is different from the observations of psychiatric
Data Loading...
